Di-n-hexyl phthalate causes Leydig cell hyperplasia in rats during puberty

•DNHP stimulates Leydig cell proliferation.•DNHP delays Leydig cell differentiation at higher doses.•DNHP down-regulates steroidogenesis-related gene expression at higher doses. Di-n-hexyl phthalate (DNHP) is commonly used as a plasticizer. However, whether DNHP influences Leydig cell development du...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology letters 2020-10, Vol.332, p.213-221
Hauptverfasser: Ye, Jianxin, Zhang, Kangnan, Yuan, Xindi, Ji, Haosen, Hu, Miner, Huang, Tongliang, Ge, Ren-Shan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•DNHP stimulates Leydig cell proliferation.•DNHP delays Leydig cell differentiation at higher doses.•DNHP down-regulates steroidogenesis-related gene expression at higher doses. Di-n-hexyl phthalate (DNHP) is commonly used as a plasticizer. However, whether DNHP influences Leydig cell development during puberty remains unexplored. In this study, DNHP (0, 10, 100, and 1000 mg/kg) was administered via gavage to 35-day-old male Sprague-Dawley rats for 21 days. Serum levels of testosterone, luteinizing hormone, follicle-stimulating hormone, Leydig cell number, the expression of Leydig and Sertoli cell genes and proteins were investigated. DNHP significantly increased serum testosterone levels at 10 mg/kg but lowered its level at 1000 mg/kg. DNHP significantly increased luteinizing hormone levels at 1000 mg/kg without affecting follicle-stimulating hormone levels. DNHP increased Leydig cell number at all doses but down-regulated the expression of Lhcgr, Hsd3b1, Hsd17b3, and Hsd11b1 in Leydig cell per se at 1000 mg/kg. DNHP elevated phosphorylation of ERK1/2 and GSK-3β at 10 mg/kg but decreased SIRT1 and PGC-1α levels at 1000 mg/kg. In conclusion, DNHP exposure causes Leydig cell hyperplasia possibly via stimulating phosphorylation of ERK1/2 and GSK-3β signaling pathways.
ISSN:0378-4274
1879-3169
DOI:10.1016/j.toxlet.2020.07.018